PlasFree

Israel
Nazareth, Northern District, Israel, 17111

Company profile

PlasFree company profile

PlasFree focuses on the development of ClearPlasma, a medical device that modifies human plasma to improve treatment for massive bleeding. ClearPlasma extracts fibrinolytic proteins that are responsible for dissolving blood clots. It modifies the human plasma generating improved plasma that is more prone to coagulation. PlasFree's product aims to revolutionize the treatment of massive bleeding and to enable safe and effective treatment to massive bleeding around the world. PlasFree was founded in 2017 and is headquartered in Nazareth, Israel.

Business identity

Contact email
[email protected]
Phone number
+972-4-609-8615
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2017-08-01

Headquarters

Postal code
17111
Country code
IL
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Last funding
Grant / $1.5M / 2021-10-06
Last equity funding
Seed
Investors
1
Lead investors
1
Founders
2

Founders and investors

Founders

Abed Elrauf HijaziZeev Dvashi

Lead investors

European Innovation Council

Investors

European Innovation Council